Does Left Atrial Appendage Closure (LAAC) provide safe and effective long-term therapy in patients with nonvalvular atrial fibrillation?
Long-term registry data supports LAAC as a safe and effective therapy for patients with nonvalvular atrial fibrillation, highlighting a very low rate of hemorrhagic stroke.
These registries, which contain the longest and largest follow-up data of patients with the Watchman device, support LAAC as a safe and effective therapy for long-term anticoagulation in patients with nonvalvular atrial fibrillation, and document the lowest rate of hemorrhagic stroke identified in this population.
Holmes et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: